MRI Tumor Regression Response to Neoadjuvant Chemotherapy Alone without Radiation for Rectal Adenocarcinoma

医学 化疗 新辅助治疗 腺癌 肿瘤科 放射治疗 完全响应 结直肠癌 放射科 直肠癌 内科学 癌症 乳腺癌
作者
Yu Shen,Xiaoling Gong,Yazhou He,Wenjian Meng,Hanjiang Zeng,Mingtian Wei,Meng Qiu,Ziqiang Wang,Shannyn Wolfe
出处
期刊:Radiology [Radiological Society of North America]
卷期号:312 (2) 被引量:5
标识
DOI:10.1148/radiol.232908
摘要

Background Neoadjuvant chemotherapy (NCT) is gaining acceptance for the management of locally advanced rectal cancer (LARC) in patients without negative prognostic factors. However, the value of MRI in evaluating tumor response after NCT remains unclear. Purpose To investigate the accuracy of MRI in assessing pathologic complete response in participants with LARC who underwent surgery after NCT without radiation. Materials and Methods A retrospective imaging substudy was conducted within two consecutive prospective clinical trials: the expanded phase II trial (from December 2017 to May 2021) and the COPEC trial (comparison of tumor response to two or four cycles of neoadjuvant chemotherapy alone, ongoing from August 2021). All included participants received four cycles of capecitabine combined with oxaliplatin (or CAPOX) before surgery. Three radiologists who were blinded to the clinicopathologic data independently evaluated the tumor response using five methods, namely, MR tumor regression grade (MR-TRG) alone, diffusion-weighted imaging (DWI) alone, DWI-modified MR-TRG (DWImodMR-TRG), MRI complete response, and radiologic neoadjuvant response score. With pathologic assessment serving as the reference standard, the positive and negative predictive values, sensitivity, specificity, and area under the receiver operating characteristic curve (AUC) were determined to evaluate the accuracy and performance of these models. The AUCs of the models were compared using the DeLong test. Results A total of 224 participants were included, comprising 119 from the expanded phase II trial (median age, 61 years [IQR, 53-67]; 89 male) and 105 from the COPEC trial (median age, 59 years [IQR, 53-67]; 65 male). MR-TRG, DWI, DWImodMR-TRG, MRI complete response, and the radiologic neoadjuvant response score were associated with pathologic complete response. DWImodMR-TRG achieved the highest AUC of 0.90 (95% CI: 0.85, 0.95), with a specificity of 89% (162 of 182) and a negative predictive value of 93% (162 of 174). Conclusion MRI-based models were accurate for determining pathologic complete response in participants with LARC following NCT. DWI improved the predictive performance of MRI-based assessment. © RSNA, 2024
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
端庄的妙菱完成签到,获得积分10
1秒前
淡定可乐完成签到,获得积分10
1秒前
芳芳发布了新的文献求助10
1秒前
GingerF应助菜根谭采纳,获得50
1秒前
1秒前
阿氏之光完成签到,获得积分10
1秒前
卡卡东完成签到 ,获得积分10
2秒前
Serrinixia完成签到,获得积分10
2秒前
踏实的绝悟完成签到 ,获得积分10
2秒前
大吉完成签到 ,获得积分10
3秒前
3秒前
ding应助Mumuiii采纳,获得10
4秒前
Owen应助111111采纳,获得10
4秒前
athena完成签到,获得积分10
4秒前
wave完成签到,获得积分10
5秒前
5秒前
5秒前
aldehyde应助PHI采纳,获得10
6秒前
悦耳孤萍发布了新的文献求助10
6秒前
美丽钢铁侠完成签到,获得积分20
7秒前
7秒前
mjx完成签到,获得积分10
8秒前
知了完成签到 ,获得积分10
8秒前
9秒前
9秒前
哈哈哈哈发布了新的文献求助10
10秒前
中央戏精学院完成签到,获得积分10
10秒前
xiaopan完成签到,获得积分10
10秒前
10秒前
11秒前
Catherine发布了新的文献求助10
12秒前
13秒前
坦率雪枫完成签到 ,获得积分10
13秒前
事上炼应助Eason采纳,获得10
13秒前
芳芳发布了新的文献求助10
13秒前
13秒前
wave发布了新的文献求助10
13秒前
69qq发布了新的文献求助10
14秒前
15秒前
15秒前
高分求助中
Encyclopedia of Quaternary Science Third edition 2025 12000
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
HIGH DYNAMIC RANGE CMOS IMAGE SENSORS FOR LOW LIGHT APPLICATIONS 1500
Constitutional and Administrative Law 1000
The Social Work Ethics Casebook: Cases and Commentary (revised 2nd ed.). Frederic G. Reamer 800
Holistic Discourse Analysis 600
Vertébrés continentaux du Crétacé supérieur de Provence (Sud-Est de la France) 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 纳米技术 计算机科学 内科学 化学工程 复合材料 物理化学 基因 遗传学 催化作用 冶金 量子力学 光电子学
热门帖子
关注 科研通微信公众号,转发送积分 5349785
求助须知:如何正确求助?哪些是违规求助? 4483501
关于积分的说明 13955962
捐赠科研通 4382679
什么是DOI,文献DOI怎么找? 2407917
邀请新用户注册赠送积分活动 1400627
关于科研通互助平台的介绍 1373868